90 related articles for article (PubMed ID: 3508484)
1. Effect of antibody to interferon on genital herpesvirus infection in mice.
Wrzos H; Murasko DM; Rapp F
Microb Pathog; 1986 Feb; 1(1):71-8. PubMed ID: 3508484
[TBL] [Abstract][Full Text] [Related]
2. Anti-interferon antibody inhibits natural killer cell activity in HSV-2 genital infection in C57BL/6J mice.
Wrzos H; Abt PL; Rapp F
Intervirology; 1990; 31(2-4):230-40. PubMed ID: 1695621
[TBL] [Abstract][Full Text] [Related]
3. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo.
Murphy JA; Duerst RJ; Smith TJ; Morrison LA
J Virol; 2003 Sep; 77(17):9337-45. PubMed ID: 12915549
[TBL] [Abstract][Full Text] [Related]
5. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
[TBL] [Abstract][Full Text] [Related]
6. Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.
Conrady CD; Halford WP; Carr DJ
J Virol; 2011 Feb; 85(4):1625-33. PubMed ID: 21147921
[TBL] [Abstract][Full Text] [Related]
7. OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production.
Oh JE; Lee MS; Kim YJ; Lee HK
Sci Rep; 2016 Jan; 6():19089. PubMed ID: 26750802
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated expression of IFN-gamma and IL-10 and impaired IFN-gamma-mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection.
Singh R; Kumar A; Creery WD; Ruben M; Giulivi A; Diaz-Mitoma F
Clin Exp Immunol; 2003 Jul; 133(1):97-107. PubMed ID: 12823283
[TBL] [Abstract][Full Text] [Related]
9. NK cells require type I IFN receptor for antiviral responses during genital HSV-2 infection.
Gill N; Chenoweth MJ; Verdu EF; Ashkar AA
Cell Immunol; 2011; 269(1):29-37. PubMed ID: 21477795
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell vaccination protects mice against lethality caused by genital herpes simplex virus type 2 infection.
Schön E; Harandi AM; Nordström I; Holmgren J; Eriksson K
J Reprod Immunol; 2001 May; 50(2):87-104. PubMed ID: 11334992
[TBL] [Abstract][Full Text] [Related]
11. RNA-dependent protein kinase is required for alpha-1 interferon transgene-induced resistance to genital herpes simplex virus type 2.
Carr DJ; Tomanek L; Silverman RH; Campbell IL; Williams BR
J Virol; 2005 Jul; 79(14):9341-5. PubMed ID: 15994831
[TBL] [Abstract][Full Text] [Related]
12. Early resolution of herpes simplex virus type 2 infection of the murine genital tract involves stimulation of genital parenchymal cells by gamma interferon.
Bird MD; Chu CF; Johnson AJ; Milligan GN
J Virol; 2007 Jan; 81(1):423-6. PubMed ID: 17065206
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
Bettahi I; Zhang X; Afifi RE; BenMohamed L
Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
[TBL] [Abstract][Full Text] [Related]
14. Role of IFN-alpha/beta signaling in the prevention of genital herpes virus type 2 infection.
Svensson A; Bellner L; Magnusson M; Eriksson K
J Reprod Immunol; 2007 Jun; 74(1-2):114-23. PubMed ID: 17092567
[TBL] [Abstract][Full Text] [Related]
15. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
16. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections.
Whaley KJ; Zeitlin L; Barratt RA; Hoen TE; Cone RA
J Infect Dis; 1994 Mar; 169(3):647-9. PubMed ID: 8158042
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of genital herpes simplex virus infection in mice. IV. Quantitative aspects of viral latency.
Eis AM; Schneweis KE
Med Microbiol Immunol; 1986; 175(5):281-92. PubMed ID: 3020386
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity to genital herpes simplex [correction of simpex] virus type 2 infection is mediated by T-bet.
Svensson A; Nordström I; Sun JB; Eriksson K
J Immunol; 2005 May; 174(10):6266-73. PubMed ID: 15879125
[TBL] [Abstract][Full Text] [Related]
19. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
[TBL] [Abstract][Full Text] [Related]
20. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
Milligan GN; Dudley-McClain KL; Young CG; Chu CF
J Reprod Immunol; 2004 Apr; 61(2):115-27. PubMed ID: 15063634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
